Prof. Giorgi Pkhakadze, MD, MPH, PhD
FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection
The FDA has approved Hepcludex as the first treatment for chronic hepatitis delta virus infection in adults without advanced cirrhosis.…
RFK Jr. Seeks Access to Americans’ Medical Records to Research Vaccine-Autism Link
U.S. Health Secretary RFK Jr. seeks federal access to medical records to research vaccine-autism links, despite decades of scientific evidence…
Pennsylvania AI Chatbot Lawsuit Reveals Critical Trust Gaps in Medical Technology
A landmark Pennsylvania lawsuit against an AI chatbot reveals critical gaps in medical technology trust and regulation. Carnegie Mellon research…
Celebrity Mental Health: Boyzone’s Ronan Keating Reveals Psychological Impact of Fame
Boyzone's Ronan Keating discusses the psychological challenges of fame, reflecting research showing entertainment industry workers face 2.5 times higher depression…
Psychologist Offers Evidence-Based Strategies to Manage Overwhelming Stress
Psychologist Kimberley Wilson outlines evidence-based strategies for managing overwhelming stress in new BBC feature. Clinical research supports structured approaches to…
NIH Official Promotes MAHA Health Strategy at American Diabetes Conference
NIH advisor Richard Woychik presented the MAHA health strategy to diabetes researchers at the American Diabetes Association conference, arguing for…
New Study Challenges Safety Assumptions About NSAIDs in Early Pregnancy
New PLOS Medicine analysis reveals the complex relationship between NSAID use and birth defects during early pregnancy. Researchers highlight challenges…
Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease Patients
Finerenone significantly reduces cardiovascular events by 14% in non-diabetic chronic kidney disease patients, according to landmark NEJM trial. The drug…